News Summary

• Ultrahuman, a Bengaluru-based health tech startup known for its smart rings, is attempting to revive its U.S. business after securing approval for its Ring Pro.
• The latest approval comes less than a month after the Ring Pro’s global launch in late February.
• The restrictions cost Ultrahuman up to $50 million in lost sales, as it was temporarily unable to import its existing Ring Air model.
• Oura, however, said the CBP decision was limited in scope and did not resolve its broader patent disputes with Ultrahuman.